Stelara Cancer Rates Up to 15 Times Higher Than Other Psoriasis Drugs, ISMP Reports
A new ISMP report warns that the psoriasis drug Stelara appears to be linked to a high rate of cancer.…
«
»
A new ISMP report warns that the psoriasis drug Stelara appears to be linked to a high rate of cancer.…
Johns Hopkins researchers warn that the drug industry is exploiting a law meant to help unprofitable drugs meant to treat small populations with rare diseases to get big, blockbuster medications onto the market.…
Arthritis drugs can lower the body’s ability to fight off infections, leading to a wide array of adverse side effects, according to a new report.…
Suicide and other psychological problems are the most frequently reported side effect of drugs given to children, researchers report.…
FDA Adverse event reports appear to show a surprisingly strong association between arthritis drugs and skin cancer.…
In 2012, there was an increase in FDA adverse event reports involving patient deaths linked to drug side effects, and a number of drugs racked up large amounts of adverse event reports, according a new report by the Institute for Safe Medication Practices (ISMP)…
An FDA advisory panel is scheduled to meet today to review whether to recommend the agency expanded the approved uses for Humira to include treatment of ulcerative colitis. However, a staff report suggests that the popular medication may not be effective for treatment of the bowel condition and may require additional studies.…
According to a recent report that summarizes adverse events associated with prescription medications, the arthritis drug Remicade and painkiller acetaminophen, which is the active ingredient in Tylenol, were the medications most commonly associated with reports of severe liver problems.…
Drugs that suppress the immune system in order to treat inflammatory bowel disease (IBD), such as Imuran, could increase the risk of skin cancer, according to the findings of two new studies. …
Federal drug regulators are warning that patients taking Enbrel, Humira and other similar drugs continue to report incidents of Hepatosplenic T-Cell Lymphoma, which could be related to the drugs’ suppression of the immune system. The FDA is now requiring drug manufacturers to track lymphoma patients taking the drugs and provide more detailed information about the risk. …